Company Search:
Advanced Search
Sponsored Links
Lavipharm SA Company Snapshot
Lavipharm SA operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lavipharm SA with three other pharmaceutical manufacturers in Europe: Moberg Pharma AB (publ) of Sweden (2016 sales of 334.30 million Swedish Kronor [US$40.81 million] of which 45% was Kerasal Nail /Nalox), Hvivo PLC of the United Kingdom (£19.85 million [US$27.68 million] of which 100% was Medical and Scientific Research), and Horizon Discovery Group PLC which is also based in the United Kingdom (£24.07 million [US$33.58 million] of which 53% was Services).

Sales Analysis. Lavipharm SA reported sales of 31.14 million Euro (US$38.25 million) for the year ending December of 2016. This represents an increase of 18.1% versus 2015, when the company's sales were 26.37 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lavipharm SA
  Stock Performance Chart for Lavipharm SA
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): .19
(Figures in Euro)
1 Week -1.0%   13 Weeks 14.1%  
4 Weeks 40.6%   52 Weeks 158.7%  
Lavipharm SA Key Data:
  Ticker: LAVI Country: Greece
  Exchanges: ATH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 31,139,000
(Year Ending Jan 2017).
Employees: 314
  Currency: Euro Market Cap: 9,909,720
  Fiscal Yr Ends: December Shares Outstanding: 51,081,030
  Share Type: Kini Metohi Closely Held Shares: 26,827,757
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.